EcoDrugPlus

Matrix Metallopeptidase 13

Ensembl ID : ENSMSIG00000018843
Gene Symbol: MMP13
1 Cross references
215 Possible Orthologues:

Matrix Metallopeptidase 14 (Membrane-Inserted)

Ensembl ID : ENSMSIG00000016218
Gene Symbol: MMP14
1 Cross references
284 Possible Orthologues:

Matrix Metallopeptidase 1a (Interstitial Collagenase)

Ensembl ID : ENSMSIG00000018671
Gene Symbol: MMP1A
1 Cross references
359 Possible Orthologues:

Matrix Metallopeptidase 1b (Interstitial Collagenase)

Ensembl ID : ENSMSIG00000018722
Gene Symbol: MMP1B
1 Cross references
351 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSMSIG00000022035
Gene Symbol: MMP2
1 Cross references
224 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSMSIG00000018686
Gene Symbol: MMP3
1 Cross references
506 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSMSIG00000018503
Gene Symbol: MMP7
1 Cross references
178 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSMSIG00000018618
Gene Symbol: MMP8
1 Cross references
126 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSMSIG00000022759
Gene Symbol: MMP9
1 Cross references
229 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSMSIG00000011592
Gene Symbol: MTOR
1 Cross references
229 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSMSIG00000013953
Gene Symbol: MC1R
1 Cross references
174 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSMSIG00000026397
Gene Symbol: MC3R
1 Cross references
153 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).